BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 2883848)

  • 1. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
    Reeves JJ; Stables R
    Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
    Stables R; Humphray JM; Reeves JJ
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():7-13. PubMed ID: 1983348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated gastric mucosa: an early approach to the study of the mechanism of action of gastric antisecretory agents.
    Colombo M; Fort M; Farré AJ
    Methods Find Exp Clin Pharmacol; 1989 Oct; 11(10):621-34. PubMed ID: 2573753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
    Decktor DL; Pendleton RG; Kellner AT; Davis MA
    J Pharmacol Exp Ther; 1989 Apr; 249(1):1-5. PubMed ID: 2565384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastric acid secretion and histamine H2 receptor antagonists].
    Gespach C; Emami S; Di Gioia Y; Chastre E
    Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
    [No Abstract]   [Full Text] [Related]  

  • 6. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
    Scarpignato C; Tramacere R; Zappia L
    Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
    Takeda M; Takagi T; Maeno H
    Eur J Pharmacol; 1983 Aug; 91(4):371-6. PubMed ID: 6137398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of H2-receptor antagonists on drug interaction in rats.
    Lin JH; Cocchetto DM; Yeh KC; Duggan DE
    Drug Metab Dispos; 1986; 14(6):649-53. PubMed ID: 2877821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of a new H2 receptor antagonist, famotidine, on gastric secretion].
    Noci MT; Coruzzi G
    Boll Soc Ital Biol Sper; 1986 Sep; 62(9):1103-9. PubMed ID: 2879549
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
    Katz LB; Tobia AJ; Shriver DA
    J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological comparison of ORF 17910, a potent, long-acting histamine H2-receptor antagonist, to cimetidine and ranitidine.
    Katz LB; Scott CK; Shriver DA
    J Pharmacol Exp Ther; 1986 Aug; 238(2):587-93. PubMed ID: 2874214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.
    Pendleton RG; Torchiana ML; Chung C; Cook P; Wiese S; Clineschmidt BV
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):4-16. PubMed ID: 6141772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
    Pendleton RG; Cook PG; Shepherd-Rose A; Mangel AW
    J Pharmacol Exp Ther; 1985 Apr; 233(1):64-9. PubMed ID: 2858583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of H2-receptor blockade on gastric mucus composition. A comparative study with ranitidine and famotidine.
    Guslandi M; Testoni PA; Masci E
    J Int Med Res; 1987; 15(4):224-6. PubMed ID: 2888693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
    Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study with oxmetidine and ranitidine on acid secretion and gastrin release in the dog.
    Soldani G; Del Tacca M; Polloni A; Bernardini C; Martinotti E
    Int J Tissue React; 1984; 6(2):181-4. PubMed ID: 6145677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.
    Nielsen ST
    J Pharmacol Exp Ther; 1987 Aug; 242(2):607-13. PubMed ID: 2886646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.